Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Assembly Biosciences discloses novel CpAM candidate

April 20, 2016

First in-human trial evaluating MVT-5873 in CA19-9-positive malignancies

April 20, 2016

Preclinical development of Trk-A inhibitor GVK-904

April 20, 2016

Novel antibacterial agent shows in vitro efficacy

April 19, 2016

IVA-337 demonstrates good safety and tolerability in phase IIa diabetes trial

April 19, 2016

NDI-010976 shows dose-dependent inhibition of de novo lipogenesis in the liver in phase Ib trial

April 19, 2016

Phase II GAMES results reported for RP-1127 for prevention of edema after ischemic stroke

April 19, 2016

Armodafinil improves daytime somnolence and psychiatric features associated with DLB

April 18, 2016

Constellation Pharmaceuticals discovers novel EZH2 methyltransferase inhibitors

April 18, 2016

Gilead's GS-9674 shows promise in treating nonalcoholic steatohepatitis

April 18, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...